← Open Payments lookup

ANN MOORE: Open Payments

NPI 1184840712 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$49,062 in 159 payments from 11 companies in 2025. Trend: 2023 $39,659 · 2024 $71,467 · 2025 $49,062

Speaker / faculty: $23,691Consulting: $12,283Travel & lodging: $6,073Food & beverage: $4,926Speaker / faculty: $1,330Honoraria: $760
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc25$14,047
ABBVIE INC.35$7,924
Gilead Sciences, Inc.36$7,404
Madrigal Pharmaceuticals27$6,433
Siemens Medical Solutions USA, Inc.5$4,910
Intercept Pharmaceuticals, Inc.8$3,108
GlaxoSmithKline, LLC.2$3,000
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$1,161
Novo Nordisk Inc2$1,009
ORPHALAN INC2$39

Products named: IQIRVO, MAVYRET, REZDIFFRA, Atellica IM 1300 Analyzer, Epclusa, OCALIVA, Bylvay, Livdelzi.

Industry payments across AZ — which companies pay providers there.